These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19070795)

  • 1. [Chemotherapy indications in the treatment of metastases from urological malignancies].
    Théodore C
    Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving role of chemotherapy in advanced urothelial cancer.
    Calabrò F; Sternberg CN
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy indications in the treatment of metastases from urological malignancies].
    Nguyen TD; Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S223-7. PubMed ID: 19070796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel agents for muscle-invasive and advanced urothelial cancer.
    Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
    BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urological cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):193-8. PubMed ID: 19223735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogeriatric evaluation for elderly patients suffering from metastatic urologic malignancies].
    Neuzillet Y; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S415-25. PubMed ID: 19070825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
    Bamias A
    Eur Urol; 2007 Oct; 52(4):1113-4. PubMed ID: 17367916
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrating metastasectomy in the management of advanced urological malignancies-where are we in 2005?
    Rasco DW; Assikis V; Marshall F
    J Urol; 2006 Nov; 176(5):1921-6. PubMed ID: 17070212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy for metastatic urothelial carcinoma.
    Lin CC; Hsu CH; Pu YS; Vogelzang NJ
    BJU Int; 2008 Apr; 101(7):795-803. PubMed ID: 18070193
    [No Abstract]   [Full Text] [Related]  

  • 11. [Surgery for thoracic metastases from urological malignancies].
    Chapelier A
    Prog Urol; 2008 Nov; 18 Suppl 7():S250-5. PubMed ID: 19070801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role and technical aspects of surgery for spinal metastases from urological malignancies].
    Gaillard S; Lepeintre JF; Aldea S; Scarone P; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S239-45. PubMed ID: 19070799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of advanced urological tumors].
    Krege S
    Onkologie; 2003 Oct; 26 Suppl 4():13-7. PubMed ID: 14605451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the pathologist in the diagnosis of metastases from urological malignancies].
    Molinié V
    Prog Urol; 2008 Nov; 18 Suppl 7():S178-95. PubMed ID: 19070790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line therapies in metastatic urothelial carcinoma.
    Narayanan S; Harshman LC; Srinivas S
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):341-59, x. PubMed ID: 25836939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The imaging aspects of metastases from urological malignancies].
    Correas JM; Méjean A; Hélénon O
    Prog Urol; 2008 Nov; 18 Suppl 7():S196-201. PubMed ID: 19070791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for urothelial cancer.
    Serrano C; Morales R; Suárez C; Núñez I; Valverde C; Rodón J; Humbert J; Padrós O; Carles J
    Cancer Treat Rev; 2012 Jun; 38(4):311-7. PubMed ID: 22113129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of brain metastases from urological malignancies].
    Gaillard S; Lebret T; Scarone P; Lepeintre JF; Méjean A; Aldea S
    Prog Urol; 2008 Nov; 18 Suppl 7():S234-8. PubMed ID: 19070798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What are the contributions of experimental studies to the diagnosis and therapy of urological tumors?].
    Debruyne FM; Oosterhof GO; Schalken JA
    Verh K Acad Geneeskd Belg; 1991; 53(1):29-37; discussion 38. PubMed ID: 2053419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.